These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6276195)

  • 1. Dose-dependent feeding in the rat following substantia nigra acetylcholinesterase blockade.
    Winn P; Redgrave P
    Eur J Pharmacol; 1981 Dec; 76(4):421-5. PubMed ID: 6276195
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of ethanolamine-O-sulphate injection into the rat substantia nigra: electrophysiological studies.
    Oakley NR; Dray A
    Brain Res; 1978 Sep; 153(2):387-91. PubMed ID: 210885
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of behaviour following stimulation of the anterior substantia nigra by direct cholinergic agonists and anticholinesterases.
    Parker GC; Inglis WL; Winn P
    Psychopharmacology (Berl); 1993; 112(2-3):242-8. PubMed ID: 7871026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
    Clarke PB; Reuben M; el-Bizri H
    Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative correlation between single unit activity and fluorescence intensity of dopamine neurones in zona compacta of substantia nigra, as demonstrated under the influence of nicotine and physostigmine.
    Lichtensteiger W; Felix D; Lienhart R; Hefti F
    Brain Res; 1976 Nov; 117(1):85-103. PubMed ID: 990937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P.
    Oblin A; Zivkovic B; Bartholini G
    Eur J Pharmacol; 1984 Oct; 105(1-2):175-7. PubMed ID: 6208042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and pharmacological specificity of the feeding elicited by cholinergic stimulation of the substantia nigra in the rat.
    Winn P; Farrell A; Maconick A; Robbins TW
    Behav Neurosci; 1983 Oct; 97(5):794-809. PubMed ID: 6639749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibition.
    Dajas F; Silveira R; Costa G; Castello ME; Jerusalinsky D; Medina J; Levesque D; Greenfield S
    Brain Res; 1993 Jul; 616(1-2):1-5. PubMed ID: 7689409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding following microinjection of cholinergic substances into substantia nigra.
    Winn P; Redgrave P
    Life Sci; 1979 Jul; 25(4):333-8. PubMed ID: 470554
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of 6-hydroxydopamine injections into the nucleus accumbens and substantia nigra on rat behavior].
    Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1992 Apr; 78(4):14-20. PubMed ID: 1334857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological studies of the role of cholecystokinin in the substantia nigra and its interactions with dopamine.
    Skirboll LR; Hommer DW
    Ann N Y Acad Sci; 1985; 448():275-82. PubMed ID: 3861121
    [No Abstract]   [Full Text] [Related]  

  • 13. D-tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons.
    Caputi L; Bengtson CP; Guatteo E; Bernardi G; Mercuri NB
    Synapse; 2003 Mar; 47(3):236-9. PubMed ID: 12494406
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of lead administration during development on lithium-induced polydipsia and dopaminergic function.
    DeHaven DL; Krigman MR; Gaynor JJ; Mailman RB
    Brain Res; 1984 Apr; 297(2):297-304. PubMed ID: 6326940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra.
    Innis RB; Aghajanian GK
    Brain Res; 1987 May; 411(1):139-43. PubMed ID: 2955848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
    Melamed E
    Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.